MAUDE adverse event: Philips Medical Systems Nederland B.V. - IntelliSpace Cardiovascular

Reported to the FDA Oct 16, 2026 (event Jun 23, 2026). The FDA publishes these reports weeks after receipt. Philips identified a software defect internally in IntelliSpace Cardiovascular (ISCV) whereby the thick client application does not adequately distinguish between legitimate and ma